Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kathleen M. Job, Jared Olson, Chris Stockmann, Jonathan E. Constance, Elena Y. Enioutina, Joseph E. Rower, Matthew W. Linakis, Alfred H. Balch, Tian Yu, Xiaoxi Liu, Emily A. Thorell & Catherine M. T. Sherwin. (2016) Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. Expert Review of Anti-infective Therapy 14:8, pages 731-746.
Read now
Read now
R Chris Rathbun & Holly L Hoffman. (2002) Review of the safety and efficacy of voriconazole. Expert Opinion on Investigational Drugs 11:3, pages 409-429.
Read now
Read now
Mohammad A Hossain & Mahmoud A Ghannoum. (2000) New investigational antifungal agents for treating invasive fungal infections. Expert Opinion on Investigational Drugs 9:8, pages 1797-1813.
Read now
Read now
Articles from other publishers (15)
Seung Min Lee, Jong Ho Park, Su Youn Suh, Sang Min Lee & Iksoo Byon. (2021) Efficacy of intravitreal povidone-iodine administration for the treatment of Candida albicans endophthalmitis in rabbits. Experimental Eye Research 212, pages 108788.
Crossref
Crossref
Andreas H. Groll & Silke Gastine. 2020. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics
185
224
.
Shmuel Shoham, Andreas H. Groll, Vidmantas Petraitis & Thomas J. Walsh. 2017. Infectious Diseases. Infectious Diseases
1333
1344.e4
.
Michael J. Dolton & Andrew J. McLachlan. (2014) Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity. International Journal of Antimicrobial Agents 44:3, pages 183-193.
Crossref
Crossref
Katsuyuki Maki & Shuji Kaneko. (2013) Effective concentration-based serum pharmacodynamics for antifungal azoles in a murine model of disseminated Candida albicans infection. European Journal of Drug Metabolism and Pharmacokinetics 38:4, pages 261-268.
Crossref
Crossref
Shmuel Shoham, Andreas H Groll & Thomas J Walsh. 2010. Infectious Diseases. Infectious Diseases
1477
1489
.
Andreas H. Groll & Thomas J. Walsh. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
3271
3308
.
Charles H. Nightingale, Paul G. Ambrose, George L. Drusano & Takeo MurakawaJohan W. Mouton. 2007. Antimicrobial Pharmacodynamics in Theory and Clinical Practice. Antimicrobial Pharmacodynamics in Theory and Clinical Practice
327
354
.
Katsuhisa Uchida, Shigeru Abe & Hideyo Yamaguchi. (2013)
The Postantifungal Effect (PAFE) of Itraconazole, in Comparison with Those of Miconazole and Fluconazole, on
Candida
Species
. Microbiology and Immunology 50:9, pages 679-685.
Crossref
Crossref
Ursula Theuretzbacher, Franziska Ihle & Hartmut Derendorf. (2006) Pharmacokinetic/Pharmacodynamic Profile of Voriconazole. Clinical Pharmacokinetics 45:7, pages 649-663.
Crossref
Crossref
M. N. Neely, D. J. Sheehan & M. A. Ghannoum. 2004. Human Fungal Pathogens. Human Fungal Pathogens
299
318
.
Susan E Orosz. (2003) Antifungal drug therapy in avian species. Veterinary Clinics of North America: Exotic Animal Practice 6:2, pages 337-350.
Crossref
Crossref
M.T. Garcı́a, M.T. Llorente, F. Mı́nguez & J. Prieto. (2002) Postantifungal Effect and Effects of Sub-MIC Concentrations on Previously Treated Candida sp. Influence of Growth Phase. Journal of Infection 45:4, pages 263-267.
Crossref
Crossref
Andreas H. Groll, Stephen C. Piscitelli & Thomas J. Walsh. (2012) Antifungal Pharmacodynamics: Concentration‐Effect Relationships in Vitro and in Vivo. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21:8P2.
Crossref
Crossref
Elizabeth S. Dodds, Richard H. Drew & John R. Perfect. (2012) Antifungal Pharmacodynamics: Review of the Literature and Clinical Applications. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20:11, pages 1335-1355.
Crossref
Crossref